Overview Financials News + Filings Key Docs Ownership Insiders
|
Graphite Bio, Inc.
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/21/2023 | Lehrer-Graiwer Joshua | PRESIDENT AND CEO | Grant | Stock Option (right to buy) | 600k | $2.18 | $1.3M | | 02/21/2023 |
| 02/21/2023 | Young Alethia | CFO | Grant | Stock Option (right to buy) | 220k | $2.18 | $479.6k | | 02/21/2023 |
| 06/21/2022 | Viney Joanne L. | Director | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 06/21/2022 | KARSEN PERRY A | Director | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 06/21/2022 | Bassan Abraham | Director | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 06/21/2022 | Carlo Rizzuto | Director | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 06/21/2022 | Porteus Matthew | Director | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 06/21/2022 | Jerel Davis | Director | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 06/21/2022 | Shah Smital | Director | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 06/21/2022 | Hege Kristen | Director | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 06/21/2022 | JIMENEZ JOSEPH | Director | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 04/12/2022 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 350k | $4.08 | $1.4M | By Samsara BioCapital, L.P. | 04/11/2022 |
| 04/11/2022 | Gutry Phil | CHIEF BUSINESS OFFICER | Purchase | Common Stock | 5k | $4.01 | $20k | | 04/11/2022 |
| 04/11/2022 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 74.5k | $4.07 | $303.1k | By Samsara BioCapital, L.P. | 04/11/2022 |
| 04/01/2022 | Young Alethia | CFO | Grant | Stock Option (right to buy) | 350k | $5.23 | $1.8M | | 04/01/2022 |
| 02/16/2022 | Gutry Phil | CHIEF BUSINESS OFFICER | Grant | Stock Option (right to buy) | 115k | $11.02 | $1.3M | | 02/16/2022 |
| 02/16/2022 | Lehrer-Graiwer Joshua | PRESIDENT AND CEO | Grant | Stock Option (right to buy) | 650k | $11.02 | $7.2M | | 02/16/2022 |
| 01/24/2022 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 23k | $8.70 | $200.1k | By Fund | 01/21/2022 |
| 01/21/2022 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 100k | $8.99 | $899k | By Fund | 01/21/2022 |
| 01/20/2022 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 43.1k | $8.92 | $384.5k | By Fund | 01/19/2022 |
| 01/19/2022 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 54.6k | $9.24 | $504.2k | By Fund | 01/19/2022 |
| 12/15/2021 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 22.3k | $10.19 | $227.5k | By Fund | 12/15/2021 |
| 11/22/2021 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 201.7k | $10.15 | $2M | By Fund | 11/22/2021 |
| 10/15/2021 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 2.3k | $12.49 | $28.7k | By Fund | 10/13/2021 |
| 10/14/2021 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 3.1k | $12.50 | $38.8k | By Fund | 10/13/2021 |
| 10/13/2021 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 45.4k | $13.22 | $600.2k | By Fund | 10/13/2021 |
| 10/08/2021 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 75k | $13.12 | $984k | By Fund | 10/06/2021 |
| 10/07/2021 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 9k | $14.94 | $134.8k | By Fund | 10/06/2021 |
| 10/06/2021 | Samsara BioCapital, L.P. | 10% Owner | Purchase | Common Stock | 61.5k | $13.83 | $850.2k | By Fund | 10/06/2021 |
| 06/29/2021 | Stultz Katherine V | COO | Conversion | Common Stock | 8.1k | $0.00 | $0 | | 01/13/2021 |
| 06/29/2021 | Stultz Katherine V | COO | Conversion | Series B Preferred Stock | 19.8k | $0.00 | $0 | | 01/13/2021 |
| 06/29/2021 | Shah Smital | Director | Purchase | Common Stock | 5.9k | $17.00 | $100k | See footnote | 04/15/2021 |
| 06/24/2021 | Carlo Rizzuto | Director | Grant | Stock Option (right to buy) | 40k | $17.00 | $680k | | 06/24/2021 |
| 06/24/2021 | Bassan Abraham | Director | Grant | Stock Option (right to buy) | 40k | $17.00 | $680k | | 06/24/2021 |
| 06/24/2021 | Jerel Davis | Director | Grant | Stock Option (right to buy) | 40k | $17.00 | $680k | | 02/16/2021 |
|
|